Regulatory Sourcebook eBook
Read the article:
Industry Organizations Assist Pharma During the Pandemic and Beyond
BioPharm International checked in with AAPS, IPEC-Americas, and PDA to get an update on how the organizations are navigating the pandemic and planning for the future.
Pharmaceutical development, manufacturing, and quality efforts are often advanced by the work of industry associations and members through conferences, training sessions, publications, and working groups. These efforts continued during the past 18 months, despite restrictions posed by the COVID-19 pandemic. The American Association of Pharmaceutical Scientists (AAPS), the International Pharmaceutical Excipients Council of the Americas (IPEC-Americas), and the Parenteral Drug Association (PDA) shared recent activities and industry contributions with BioPharm International.
Read the article:
Industry Organizations Assist Pharma During the Pandemic and Beyond
BioPharm International
eBook: Regulatory Sourcebook eBook
October 2021
Pages: 30-33
When referring to this article, please cite it as BioPharm International Editors, "Industry Organizations Assist Pharma During the Pandemic and Beyond," BioPharm International Regulatory Sourcebook eBook, October 2021.
almost 4 years ago
NIST Proposes Clarifications to Bayh-Dole March-in Rights Regulationsalmost 4 years ago
How Artificial Intelligence Impacts the Global Regulatory Environmentalmost 4 years ago
Selecting the Right CMC Strategy for Biologicsalmost 4 years ago
The Evolving Biosimilar Approachalmost 4 years ago
Serialization and Aggregation from a Manufacturing Perspectivealmost 4 years ago
The Real Danger of Substandard and Counterfeit COVID-19 Vaccinesalmost 4 years ago
Collecting Industry’s Thoughts on FDA FARS ReportStay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.